Compare PFE & MCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | MCO |
|---|---|---|
| Founded | 1849 | 1900 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 80.7B |
| IPO Year | 2013 | 1998 |
| Metric | PFE | MCO |
|---|---|---|
| Price | $25.64 | $444.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | $29.29 | ★ $543.75 |
| AVG Volume (30 Days) | ★ 24.4M | 916.4K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | ★ 6.55% | 0.90% |
| EPS Growth | N/A | ★ 21.40 |
| EPS | 0.47 | ★ 3.73 |
| Revenue | ★ $62,579,000,000.00 | $4,204,100,000.00 |
| Revenue This Year | N/A | $8.25 |
| Revenue Next Year | N/A | $7.82 |
| P/E Ratio | ★ $55.39 | $121.01 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.11 | $402.28 |
| 52 Week High | $28.75 | $546.88 |
| Indicator | PFE | MCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 46.52 |
| Support Level | $25.02 | $442.22 |
| Resistance Level | $25.99 | $450.66 |
| Average True Range (ATR) | 0.43 | 11.05 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 29.73 | 43.14 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.